Feedback of individual parenteral nutrition production with Logipren®

Introduction and objectives

The DGOS instruction of March 2015 about the risk management of parenteral nutrition (PN) stresses the need to computerize neonatal prescriptions. We tested the implementation of a new pediatric software, developed by the French Society of Neonatalogy (FSN).
Our objective was to evaluate the benefit and the pertinence of Logipren® on PN risks.

Material and methods

The software has been set up after an experimentation on a test base in order to assess the configuration, to modify our functioning, to train the different actors (physicians, nurses, pharmacists, pharmacy technicians) and to realize a risk analysis.

Results

Software configuration is easier because of utilization of national guidelines (validated by FSN) and exchanges with other users.

Logipren® offers a common interface between the physician and the pharmacist, which allows an easier transmission of prescription, avoid the risk of losing information and remove retyping errors in our production software, with a time gain of 45 minutes.

An organizational change added the pharmacist into the prescription step with a better management of production issues (overfill, minimum volums…), a better information on patients and a diminution of job interrupts.

The test base permitted to communicate with the software editor about some problems (items of the label, different rounding off, and improvement of bag numbering…)

Conclusion

The implementation of Logipren® has decreased risks associated with PN bags production by reducing the number of steps and by increasing the physician/pharmacist link. However, this software does not exempt of elementary controls which allow us to detect unidentified issues during tests and since the beginning of production.